IBD Flare Action Plan: What to Track, Who to Call, and When to Seek Urgent Care

A flare rarely announces itself cleanly. Stools get looser, urgency creeps back, a little blood appears, and the question becomes whether this is inflammatory bowel disease (IBD) becoming active again, a stomach bug, something you ate, or a partial blockage. An IBD flare action plan answers that question in advance by defining what you record, who you contact, and which symptoms mean you stop waiting and get evaluated the same day. The plan matters most in the first 48 to 72 hours, when the information you can hand your gastroenterology team determines how quickly they can act.

What to Track When Symptoms Change

The two measures clinicians use most for ulcerative colitis are stool frequency and rectal bleeding, so those belong at the top of any log. Severity in ulcerative colitis is graded partly by count: the National Institute of Diabetes and Digestive and Kidney Diseases describes severe disease as more than six bowel movements a day with frequent bleeding, and extremely severe disease as more than 10 bloody bowel movements a day. Recording an actual number gives your team something to grade. "Worse than usual" does not.

Alongside counts, note nocturnal awakenings, urgency, abdominal pain and its location, oral temperature, weight, and whether you are keeping fluids down. Track medication doses taken and missed, plus any new drugs. Nonsteroidal anti-inflammatory drugs deserve their own line, because NSAID use has been associated with an increased risk of clinical relapse in IBD.

Objective markers close the loop. AGA guidance for ulcerative colitis suggests that a fecal calprotectin under 150 micrograms per gram with a normal C-reactive protein helps rule out active inflammation, while a value above 150 in someone with moderate to severe symptoms can inform treatment decisions without immediate endoscopy. Parallel AGA guidance for Crohn's disease supports a biomarker- and symptom-based monitoring strategy rather than symptoms alone. Asking for a calprotectin and CRP early is often the fastest way to separate inflammation from everything else.

Flare, Infection, Food Reaction, or Obstruction

Four possibilities explain most sudden symptom changes in IBD, and they lead to different actions. Infection is the one that must be excluded first, because treating it as a flare and increasing immunosuppression can make it worse. AGA guidance states that clinicians should test patients presenting with a flare of underlying IBD for Clostridioides difficile infection. Because carriage is common in IBD, a two-step testing algorithm is used to separate true infection from colonization, alongside stool testing for bacterial pathogens such as Salmonella, Shigella, and Campylobacter. Recent antibiotics or a sick household contact raise the odds further.

Food-related and functional symptoms are common and usually distinguishable by their markers. A meta-analysis of 3,169 patients found a pooled prevalence of irritable bowel syndrome-type symptoms of 32.5% among people with IBD in remission. Cramping, bloating, and loose stools with no blood, no fever, and normal calprotectin point in that direction, though only testing confirms it.

Obstruction is the possibility unique to Crohn's disease and the one with the shortest fuse. Symptomatic intestinal strictures develop in more than one third of patients with Crohn's disease within 10 years of disease onset, and NIDDK defines intestinal obstruction as a partial or total blockage of the movement of food, fluid, air, or stool through the intestines. Pain that builds after meals, visible distension, repeated vomiting, and no passage of gas or stool describe a pattern that needs imaging, not a diet change.

Red Flags That Mean Urgent Evaluation

Some symptom combinations are treated as severe by definition rather than by judgment. Acute severe ulcerative colitis is defined as six or more bloody stools a day plus at least one marker of systemic toxicity: temperature at or above 37.8 degrees Celsius, hemoglobin below 10.5 grams per deciliter, an erythrocyte sedimentation rate above 30 millimeters per hour, elevated C-reactive protein, or a pulse of 90 beats per minute or higher. You can measure two of those at home. Frequent bloody stools with a fever or a resting pulse above 90 warrants same-day contact and, if your team is unreachable, emergency evaluation. Waiting is costly: up to 30% of patients admitted with acute severe colitis require colectomy during that initial admission.

Emergency department evaluation is appropriate for severe rectal bleeding, a rigid or markedly distended abdomen, severe constant pain, repeated vomiting with inability to keep liquids down, or signs of dehydration such as fainting. NIDDK notes that severe and fulminant ulcerative colitis is most often treated in a hospital, and that surgery may be needed for life-threatening complications including severe rectal bleeding, toxic megacolon, or perforation of the large intestine. One caution belongs in every plan: antidiarrheal, anticholinergic, and opioid medications should be avoided in severe colitis because they may increase the risk of colonic dilatation.

Who to Call and in What Order

Your gastroenterology practice is the first call for any sustained change, ideally through the patient portal for documentation and by phone when symptoms are escalating. Give them the numbers you have been tracking, your current medications and last dose dates, recent antibiotic exposure, and your most recent calprotectin and CRP if you know them. That package usually generates same-week stool testing and labs rather than a wait-and-see reply.

Primary care can cover stool studies and basic labs when GI access is slow, and urgent care can rehydrate and image. Neither substitutes for the specialist decisions that follow, since current guidance has shifted toward earlier escalation. The 2025 ACG Crohn's disease guideline supports initiating advanced therapy in appropriate moderate to severe cases rather than requiring failure of conventional drugs first, and limits systemic corticosteroids to fewer than three months. The ACG also published a 2025 update to its ulcerative colitis guideline for adults.

Writing the Plan Down Before You Need It

A usable plan fits on one page and is written while you are well. It should name your baseline in numbers, list your medications with doses and dates, record allergies and prior drug reactions, and hold your GI office number, after-hours line, and the hospital your team prefers you use. Add your last calprotectin, CRP, and hemoglobin values so a clinician meeting you for the first time has a comparison point.

The value of the plan comes from having decided in advance where the thresholds sit. When symptoms change, the work becomes recording numbers, running the four possibilities, and matching what you see against criteria set when you could think clearly. Review those thresholds with your own gastroenterology team, since disease extent, prior surgery, and current therapy all shift where the lines belong.